Why one trial participant's healthy birth after her CAR-T treatment for lupus is catching resesarchers' attention: ...
Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good morning, and welcome to the BioXcel Therapeutics Third ...
Vincent O'Neill; Executive Vice President, Chief of Product Development and Medical Officer; BioXcel Therapeutics Inc Alec Stranahan; Analyst; BofA Securities, Inc.
If your son takes a BB gun or a real gun out on me, I’m gonna kill your son. ... So, if you have a problem with that, don’t ...
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
Why It Matters: The appointment of Kennedy, a prominent critic of vaccines, as Health Secretary could signal a shift in ...
AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...
Objective Treatment compliance among psychiatric patients is related to disease outcomes. How to assess patient compliance remains a concern. Here, we established a predictive model for medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback